Centre for the Control and Evaluation of Medicines, Chemical Medicines Unit, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy.
Department of Chemistry and Technology of Drugs, Sapienza University of Rome, 00185 Rome, Italy.
Molecules. 2021 Mar 20;26(6):1747. doi: 10.3390/molecules26061747.
The couple of chiral sulfur compounds α-lipoic acid (ALA)/α-dihydrolipoic acid (DHALA) has attracted considerable attention in recent years owing to its remarkable anti-inflammatory and antioxidant properties. It is well known that the chirality of the C6 plays a key role in determining the biological activity of ALA. The natural occurring ()-ALA enantiomer is an essential cofactor for key oxidative metabolism enzyme complexes and, after oral administration of the racemic mixture, it shows higher plasma concentration than ()-ALA. Differently, the in vivo enantioselective action difference between the enantiomers of DHALA has not yet been studied. This lacking is perhaps due to the unavailability of analytical methods capable of determining the enantiomeric composition of biological samples during pharmacokinetic and pharmacodynamic events. In the present work, the direct and baseline enantioresolution of both chiral acids by HPLC on two amylose-derived chiral stationary phases is presented. The proposed chiral enantioselective protocol, therefore, does not require pre- or on-column derivatization. The performance of the coated Chiralpak AS-H CSP and the new immobilized Chiralpak IH-3 CSP, which have the same chiral selector amylose tris-[()-α-methylbenzylcarbamate], were compared using conventional normal-phase mobile phases containing ethanol or 2-propanol as alcoholic solvents and a fixed percentage of trifluoroacetic acid. Nonconventional eluents containing dichloromethane, ethyl acetate, and 2-methyltetrahydrofuran as organic cosolvents were applied in the separation of the enantiomers of two carboxylic acids on the immobilized Chiralpak IH-3 CSP. The effect of the column temperature was carefully evaluated in order to improve enantioselectivity. Adequate amounts of enantiomers were isolated by an analytical-size Chiralpak IH-3 column and submitted to chiroptical measurements. The absolute configuration assignment of the isolated enantiomers was determined by a multidisciplinary procedure based on the comparison of the experimental and calculated chiroptical properties.
近年来,由于具有显著的抗炎和抗氧化特性,一对手性硫化合物 α-硫辛酸 (ALA)/α-二氢硫辛酸 (DHALA) 引起了相当大的关注。众所周知,C6 的手性在确定 ALA 的生物活性方面起着关键作用。天然存在的 ()-ALA 对映体是关键氧化代谢酶复合物的必需辅因子,并且在口服外消旋混合物后,其血浆浓度高于 ()-ALA。不同的是,DHALA 对映体之间的体内对映选择性作用差异尚未得到研究。这种缺乏可能是由于缺乏能够在药代动力学和药效学事件中确定生物样品对映体组成的分析方法。在本工作中,通过 HPLC 在两种直链淀粉衍生的手性固定相上直接和基线拆分这两种手性酸。因此,所提出的手性对映选择性方案不需要预柱或柱上衍生化。比较了涂敷的 Chiralpak AS-H CSP 和新型固定化 Chiralpak IH-3 CSP 的性能,这两种手性固定相都使用含有乙醇或 2-丙醇作为醇溶剂和固定百分比三氟乙酸的常规正相流动相。在固定化 Chiralpak IH-3 CSP 上分离两种羧酸的对映体时,应用了含有二氯甲烷、乙酸乙酯和 2-甲基四氢呋喃作为有机共溶剂的非传统洗脱液。仔细评估了柱温对提高对映选择性的影响。通过分析尺寸的 Chiralpak IH-3 柱分离出足够量的对映体,并提交进行旋光测量。通过基于比较实验和计算旋光性质的多学科程序确定分离对映体的绝对构型。